Young Richard A 4
4 · Syros Pharmaceuticals, Inc. · Filed Sep 18, 2024
Insider Transaction Report
Form 4
Young Richard A
Director
Transactions
- Exercise/Conversion
Restricted Stock Units
2024-09-16−2,667→ 2,667 total→ Common Stock (2,667 underlying) - Exercise/Conversion
Common Stock
2024-09-16+2,667→ 10,667 total
Footnotes (3)
- [F1]Represents shares of common stock received upon vesting of a restricted stock unit ("RSU") award
- [F2]Each RSU represents the contingent right to receive one share of the issuer's common stock.
- [F3]Represents a restricted stock unit award granted on September 16, 2022. These restricted stock units vest in three equal annual installments commencing on September 16, 2023.